$1.980
0.000 (0.00%)收盘时
价格预测
在 App 中打开以解锁更长周期的预测。
ALLO 相似图表分析预测
Alphio's ALLO stock price prediction model matches the current Allogene Therapeutics, Inc. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $2.12 (+7.26%). The 1-week path is $2.13 (+7.33%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
该买入 Allogene Therapeutics, Inc. 股票吗？
Allogene Therapeutics Inc (ALLO) is a good buy right now, trading at $2.02 with a recent RSI of 44.57, suggesting it is not overbought. The company has shown a 49.63% year-to-date increase, and analysts see potential price targets up to $11, indicating a strong upside. However, the main risk is the ongoing financial losses, with a reported net income loss of $42.68 million in Q2 2026, which could impact investor confidence.
ALLO 股价于 Thursday 收于 $1.98，此前上涨 0.00%
Allogene Therapeutics, Inc. (ALLO) last closed at $1.98, gaining +0.00%. These facts feed the 1-day and 1-week ALLO price prediction above.
分析师一致预期
Allogene Therapeutics, Inc.（ALLO）：买入 3、持有 1、卖出 0。展望：Buy。
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
预测驱动因素
Allogene Therapeutics, Inc.（ALLO）的预测驱动因素综合了相似的图表形态、季节性与移动平均线。
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bullish
相似图表形态
近期走势与 ALLO 最接近的股票，按相似度排序。
ALLO 季节性分析
Historically the probability of a positive September return for ALLO is 6.82%. February offers the highest probability of a positive month at 72.41%, while October is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
本页仅供研究参考，不构成投资建议。模型可能出错。过往表现不代表未来结果。